These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Antagonism of host antiviral responses by Kaposi's sarcoma-associated herpesvirus tegument protein ORF45. Zhu FX; Sathish N; Yuan Y PLoS One; 2010 May; 5(5):e10573. PubMed ID: 20485504 [TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis. Zuo J; Hislop AD; Leung CS; Sabbah S; Rowe M J Virol; 2013 May; 87(10):5340-50. PubMed ID: 23449805 [TBL] [Abstract][Full Text] [Related]
31. Caspase-Dependent Suppression of Type I Interferon Signaling Promotes Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Tabtieng T; Degterev A; Gaglia MM J Virol; 2018 May; 92(10):. PubMed ID: 29514903 [TBL] [Abstract][Full Text] [Related]
32. Identification of the Essential Role of Viral Bcl-2 for Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Liang Q; Chang B; Lee P; Brulois KF; Ge J; Shi M; Rodgers MA; Feng P; Oh BH; Liang C; Jung JU J Virol; 2015 May; 89(10):5308-17. PubMed ID: 25740994 [TBL] [Abstract][Full Text] [Related]
33. Novel Role of vBcl2 in the Virion Assembly of Kaposi's Sarcoma-Associated Herpesvirus. Liang Q; Wei D; Chung B; Brulois KF; Guo C; Dong S; Gao SJ; Feng P; Liang C; Jung JU J Virol; 2018 Feb; 92(4):. PubMed ID: 29167347 [TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. Li M; Lee H; Guo J; Neipel F; Fleckenstein B; Ozato K; Jung JU J Virol; 1998 Jul; 72(7):5433-40. PubMed ID: 9620998 [TBL] [Abstract][Full Text] [Related]
35. Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis. Yan L; Majerciak V; Zheng ZM; Lan K Virol Sin; 2019 Apr; 34(2):135-161. PubMed ID: 31025296 [TBL] [Abstract][Full Text] [Related]
36. Signal Transduction Pathways Associated with KSHV-Related Tumors. Watanabe T; Sugimoto A; Hosokawa K; Fujimuro M Adv Exp Med Biol; 2018; 1045():321-355. PubMed ID: 29896674 [TBL] [Abstract][Full Text] [Related]
37. vIRF3 encoded by Kaposi's sarcoma-associated herpesvirus inhibits T-cell factor-dependent transcription via a CREB-binding protein-interaction motif. Cha S; Choe J; Seo T Biochem Biophys Res Commun; 2016 Oct; 479(4):697-702. PubMed ID: 27693583 [TBL] [Abstract][Full Text] [Related]
38. Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview. Sathish N; Yuan Y J Virol; 2011 Nov; 85(21):10934-44. PubMed ID: 21775463 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. Li Q; Means R; Lang S; Jung JU J Virol; 2007 Mar; 81(5):2117-27. PubMed ID: 17166914 [TBL] [Abstract][Full Text] [Related]
40. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration. Giffin L; West JA; Damania B mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]